Unveiling the Role of Mucosal-Associated Invariant T Cells in Peritoneal Fibrosis and Its Therapeutic Targeting

Background: One of the most common causes of discontinued peritoneal dialysis (PD) is progressive peritoneal fibrosis. Persistent low-grade inflammation induced by PD treatment is a driving force of peritoneal fibrogenesis. Mucosal-associated invariant T (MAIT) cells, known for their role in immune responses against microbial infections, have also been implicated in various inflammatory and fibrotic diseases. Despite their known importance, the specific mechanisms through which MAIT cells contribute to peritoneal fibrosis remain poorly understood. Methods: Utilizing single-cell RNA sequencing (scRNA-seq) and flow cytometry, we characterized the activation and function of peritoneal MAIT cells from patients receiving long-term peritoneal dialysis (PD). We explored the molecular pathways activated by these cells, focusing on the MR1-mediated interaction with mesothelial cells and the subsequent activation of the mTORC1 signaling pathway. The effects of MAIT cell inhibition on fibrogenesis were examined using both in vitro models and Mr1 knockout mice. Results: Our findings indicate that long-term PD enhances the activation of MAIT cells, specifically increasing the population of pro-inflammatory MAIT17 subtype cells. These cells contribute to peritoneal fibrosis by binding to the MR1 receptor on mesothelial cells, inducing hyperglycolysis via the mTORC1 pathway, which leads to peritoneal fibrogenesis. Furthermore, we demonstrate that blocking the MR1-MAIT interaction, either through genetic knockout or pharmacological inhibition with Ac-6-FP, mitigates fibrosis, suggesting a novel therapeutic strategy. Conclusion: This study underscores the crucial role of MAIT cells in the pathogenesis of peritoneal fibrosis and identifies them as potential targets for therapeutic intervention. The findings suggest that while some aspects of MAIT cell involvement in fibrosis are beginning to be understood, comprehensive insights into their roles in various pathological conditions remain limited, warranting further investigation.

Authors

Institutions

Publication Details

Journal
Journal of the American Society of Nephrology
Published
2024-10-01
DOI
https://doi.org/10.1681/asn.2024hhysqxkq
Primary Topic
Eosinophilic Esophagitis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Unveiling the Role of Mucosal-Associated Invariant T Cells in Peritoneal Fibrosis and Its Therapeutic Targeting

Yuxiang Sun, Hui Peng, Qiang Huang
Journal of the American Society of Nephrology
Eosinophilic Esophagitis
article

Unveiling the Role of Mucosal-Associated Invariant T Cells in Peritoneal Fibrosis and Its Therapeutic Targeting

Yuxiang Sun, Hui Peng, Qiang Huang
article en

Abstract

Background: One of the most common causes of discontinued peritoneal dialysis (PD) is progressive peritoneal fibrosis. Persistent low-grade inflammation induced by PD treatment is a driving force of peritoneal fibrogenesis. Mucosal-associated invariant T (MAIT) cells, known for their role in immune responses against microbial infections, have also been implicated in various inflammatory and fibrotic diseases. Despite their known importance, the specific mechanisms through which MAIT cells contribute to peritoneal fibrosis remain poorly understood. Methods: Utilizing single-cell RNA sequencing (scRNA-seq) and flow cytometry, we characterized the activation and function of peritoneal MAIT cells from patients receiving long-term peritoneal dialysis (PD). We explored the molecular pathways activated by these cells, focusing on the MR1-mediated interaction with mesothelial cells and the subsequent activation of the mTORC1 signaling pathway. The effects of MAIT cell inhibition on fibrogenesis were examined using both in vitro models and Mr1 knockout mice. Results: Our findings indicate that long-term PD enhances the activation of MAIT cells, specifically increasing the population of pro-inflammatory MAIT17 subtype cells. These cells contribute to peritoneal fibrosis by binding to the MR1 receptor on mesothelial cells, inducing hyperglycolysis via the mTORC1 pathway, which leads to peritoneal fibrogenesis. Furthermore, we demonstrate that blocking the MR1-MAIT interaction, either through genetic knockout or pharmacological inhibition with Ac-6-FP, mitigates fibrosis, suggesting a novel therapeutic strategy. Conclusion: This study underscores the crucial role of MAIT cells in the pathogenesis of peritoneal fibrosis and identifies them as potential targets for therapeutic intervention. The findings suggest that while some aspects of MAIT cell involvement in fibrosis are beginning to be understood, comprehensive insights into their roles in various pathological conditions remain limited, warranting further investigation.

Journal of the American Society of NephrologyVol. 35(10S)
Sun Yat-sen University (CN), Third Affiliated Hospital of Sun Yat-sen University (CN)
Good health and well-being
Openalex Percentile: Top 64%
Eosinophilic Esophagitis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.